sulpiride and Colitis, Mucous studies

sulpiride and Colitis, Mucous

sulpiride has been researched along with Colitis, Mucous in 3 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Research Excerpts

Excerpt	Relevance	Reference
"Metformin attenuated the visceral allodynia and increased gut permeability in animal IBS models."	7.91	Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. ( Kumei, S; Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019)
"Metformin attenuated the visceral allodynia and increased gut permeability in animal IBS models."	3.91	Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. ( Kumei, S; Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019)
"The visceral pain was assessed by electrophysiologically measuring the threshold of abdominal muscle contractions in response to colonic distention."	1.51	Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. ( Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (33.33)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Nozu, T	2
Miyagishi, S	2
Nozu, R	2
Takakusaki, K	2
Okumura, T	2
Kumei, S	1
Osipenko, MF	1
Bikbulatova, EA	1
Frolova, NN	1
Loseva, NV	1

Studies

Nozu, T

Miyagishi, S

Nozu, R

Takakusaki, K

Okumura, T

Kumei, S

Osipenko, MF

Bikbulatova, EA

Frolova, NN

Loseva, NV

Trials

1 trial available for sulpiride and Colitis, Mucous

Article	Year
[Complex therapy of patients with the irritable bowel syndrome]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2004, Issue:5 Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged;	2004

Article

Year

[Complex therapy of patients with the irritable bowel syndrome].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2004, Issue:5

Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged;

2004

Other Studies

2 other studies available for sulpiride and Colitis, Mucous

Article	Year
Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. Scientific reports, 2019, 12-20, Volume: 9, Issue:1 Topics: Animals; Butyrates; Colon; Disease Models, Animal; Electrodes; Hyperalgesia; Inflammation; Irritable	2019
Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:1 Topics: AMP-Activated Protein Kinases; Animals; Colon; Disease Models, Animal; Domperidone; Dopamine Antagon	2019

Article

Year

Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.

Scientific reports, 2019, 12-20, Volume: 9, Issue:1

Topics: Animals; Butyrates; Colon; Disease Models, Animal; Electrodes; Hyperalgesia; Inflammation; Irritable

2019

Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.

Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:1

Topics: AMP-Activated Protein Kinases; Animals; Colon; Disease Models, Animal; Domperidone; Dopamine Antagon

2019